PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
05-Apr-2022 Aptamer’s leadership and technical achievements are recognised Aptamer
05-Apr-2022 CluePoints Continues Impressive Global Growth with Three New Senior Appointments CluePoints
05-Apr-2022 ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East ArisGlobal
05-Apr-2022 AXON hires a Global Healthcare Insights and Strategy Lead AXON
30-Mar-2022 Tower Cold Chain launches KTEvolution container for pharmaceutical transport Tower Cold Chain
30-Mar-2022 New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections Novartis
29-Mar-2022 Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors AstraZeneca
29-Mar-2022 RECORDATI RARE DISEASES ANNOUNCE PUBLICATION IN THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM OF THE PHASE III LINC 4 STUDY CONFIRMING THE EFFICACY AND SAFETY OF ISTURISA® (OSILODROSTAT) IN PATIENTS WITH CUSHING’S DISEASE Recordati Rare Diseases
25-Mar-2022 ICR welcomes FDA approval of ‘search and destroy’ treatment The Institute of Cancer Research
25-Mar-2022 Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Tiziana Life Sciences Ltd
25-Mar-2022 XFret Wins the 2021 Sustainability Award – Startup/Small Business Category TIACA
25-Mar-2022 TIACA Announces the Take-Off of the BlueSky Program TIACA
25-Mar-2022 Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing Jazz Pharmaceuticals
25-Mar-2022 Envirotainer’s Releye® RAP container already approved by 10 airlines Envirotainer
24-Mar-2022 Citizens can generate novel and high-impact research questions for science BlueSky Education
23-Mar-2022 Moberg Pharma announces regulatory submission to FDA for North American phase 3 study Moberg Pharma
22-Mar-2022 Innovative collaboration to offer heart rhythm checks throughout the North West to detect Atrial Fibrillation via Community Pharmacies Daiichi Sankyo and O’Brien’s Pharmacies Group
22-Mar-2022 Zygel’s anticipated impact on underserved fragile X syndrome market sees sales estimates of $18.1 million, says GlobalData Zynerba Pharmaceuticals
22-Mar-2022 Sajid Javid is sticking his head in the sand, expert warns, as long Covid cases mount and immunity falls London Medical Laboratory
22-Mar-2022 CELL AND GENE THERAPY CATAPULT LAUNCHES 2021 CLINICAL TRIALS DATABASE REPORT The Cell and Gene Therapy Catapult (CGT Catapult)